# To Evaluate the Impact of MRSA Nasal Screen Implementation.

> **NCT07748143** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 21 (actual)

## Conditions studied

- MRSA

## Interventions

- **OTHER:** Duration of therapy
- **OTHER:** Direct Cost
- **OTHER:** Pharmacokinectic Monitoring
- **OTHER:** Hospital stay

## Key facts

- **NCT ID:** NCT07748143
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-10
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748143, "To Evaluate the Impact of MRSA Nasal Screen Implementation.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*